There were 118 patients enrolled in the study. Adopting an on-protocol approach,
patients who did not return at follow-up (n = 22) or complete the intervention (n = 5) were
excluded from the analyses, resulting in a sample of participants who completed all phases
of the research (n = 91). Loss of randomized participants from the analyzed data set was
generally comparable across conditions (11 and 16 in the treatment and control arm,
respectively), and evaluation of preintervention group equivalence did not reveal differences
in the measured variables (see Table 2).